BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17927588)

  • 1. HER-2/neu and p27Kip1 in progression of Fallopian tube carcinoma: an immunohistochemical and array comparative genomic hybridization study.
    Nowee ME; Dorsman JC; Piek JM; Kosma VM; Hämäläinen K; Verheijen RH; van Diest PJ
    Histopathology; 2007 Nov; 51(5):666-73. PubMed ID: 17927588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
    Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
    Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA profiling of primary serous ovarian and fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification.
    Nowee ME; Snijders AM; Rockx DA; de Wit RM; Kosma VM; Hämäläinen K; Schouten JP; Verheijen RH; van Diest PJ; Albertson DG; Dorsman JC
    J Pathol; 2007 Sep; 213(1):46-55. PubMed ID: 17668415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide-array-based comparative genomic hybridization reveals genetic homogeneity and frequent copy number increases encompassing CCNE1 in fallopian tube carcinoma.
    Snijders AM; Nowee ME; Fridlyand J; Piek JM; Dorsman JC; Jain AN; Pinkel D; van Diest PJ; Verheijen RH; Albertson DG
    Oncogene; 2003 Jul; 22(27):4281-6. PubMed ID: 12833150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AQUA and FISH analysis of HER-2/neu expression and amplification in a small cell lung carcinoma tissue microarray.
    Giltnane JM; Murren JR; Rimm DL; King BL
    Histopathology; 2006 Aug; 49(2):161-9. PubMed ID: 16879393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 and Her-2/neu in juvenile angiofibromas.
    Schick B; Veldung B; Wemmert S; Jung V; Montenarh M; Meese E; Urbschat S
    Oncol Rep; 2005 Mar; 13(3):453-7. PubMed ID: 15706416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of HER-2/neu overexpression on chemoresistance and prognosis in ovarian carcinoma.
    Sasaki N; Kudoh K; Kita T; Tsuda H; Furuya K; Kikuchi Y
    J Obstet Gynaecol Res; 2007 Feb; 33(1):17-23. PubMed ID: 17212661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER-2/neu gene amplification in ovarian tumours: a comprehensive immunohistochemical and FISH analysis on tissue microarrays.
    Mayr D; Kanitz V; Amann G; Engel J; Burges A; Löhrs U; Diebold J
    Histopathology; 2006 Jan; 48(2):149-56. PubMed ID: 16405663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization.
    Matsubara H; Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Honda N
    Oncol Rep; 2008 Jan; 19(1):57-63. PubMed ID: 18097576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Her-2/neu in barrett esophagus: a comparative study between histology, immunohistochemistry, and fluorescence in situ hybridization.
    Rossi E; Villanacci V; Bassotti G; Casa DD; Missale G; Minelli L; Cestari R
    Diagn Mol Pathol; 2006 Sep; 15(3):125-30. PubMed ID: 16932066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of p53 and HER-2/neu and c-myc in primary fallopian tube carcinoma.
    Chung TK; Cheung TH; To KF; Wong YF
    Gynecol Obstet Invest; 2000; 49(1):47-51. PubMed ID: 10629373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging role of the distal Fallopian tube and p53 in pelvic serous carcinogenesis.
    Herrington CS; McCluggage WG
    J Pathol; 2010 Jan; 220(1):5-6. PubMed ID: 19882674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of p53, p27(kip1), and alpha-catenin for progression in superficial bladder carcinoma.
    Schrier BP; Vriesema JL; Witjes JA; Kiemeney LA; Schalken JA
    Eur Urol; 2006 Jul; 50(1):76-82. PubMed ID: 16413663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acinic cell carcinoma with high-grade transformation: a report of 9 cases with immunohistochemical study and analysis of TP53 and HER-2/neu genes.
    Skálová A; Sima R; Vanecek T; Muller S; Korabecna M; Nemcova J; Elmberger G; Leivo I; Passador-Santos F; Walter J; Rousarova M; Jedlickova K; Curik R; Geierova M; Michal M
    Am J Surg Pathol; 2009 Aug; 33(8):1137-45. PubMed ID: 19461506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphological features of the fimbria of the fallopian tube in pelvic serous adenocarcinoma].
    Guo DH; Pang SJ; Shen Y; Li Y
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):287-90. PubMed ID: 21575501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization.
    Wang X; MacLennan GT; Zhang S; Montironi R; Lopez-Beltran A; Tan PH; Foster S; Baldridge LA; Cheng L
    Hum Pathol; 2009 Feb; 40(2):211-7. PubMed ID: 18799188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
    Lee Y; Miron A; Drapkin R; Nucci MR; Medeiros F; Saleemuddin A; Garber J; Birch C; Mou H; Gordon RW; Cramer DW; McKeon FD; Crum CP
    J Pathol; 2007 Jan; 211(1):26-35. PubMed ID: 17117391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation.
    Kazakov DV; Ivan D; Kutzner H; Spagnolo DV; Grossmann P; Vanecek T; Sima R; Kacerovska D; Shelekhova KV; Denisjuk N; Hillen U; Kuroda N; Mukensnabl P; Danis D; Michal M
    Am J Dermatopathol; 2009 May; 31(3):236-47. PubMed ID: 19384064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-erbB-2 and p53 expression in fallopian tube carcinoma.
    Lacy MQ; Hartmann LC; Keeney GL; Cha SC; Wieand HS; Podratz KC; Roche PC
    Cancer; 1995 Jun; 75(12):2891-6. PubMed ID: 7773939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.